Literature DB >> 2836209

Angiotensin effects on vas deferens adrenergic and purinergic neurotransmission.

G J Trachte1.   

Abstract

Angiotensin effects on purinergic and adrenergic neurotransmission in the rabbit vas deferens were examined. Both angiotensins inhibited the non-adrenergic, and potentiated the adrenergic, neurogenic contraction. Angiotensin III inhibited the non-adrenergic neurogenic contraction to a greater extent than angiotensin II at all concentrations tested (maximal inhibition being 42 +/- 4 vs. 17 +/- 3% for angiotensin II). Angiotensin II was more potent than angiotensin III at potentiating adrenergic neurotransmission. Neither peptide altered the postjunctional action of either putative neurotransmitter, ATP or norepinephrine. These results are inconsistent with the hypothesis that ATP and norepinephrine are released in constant ratios. Furthermore, the different pattern of angiotensin responses is consistent with the existence of at least two separate angiotensin receptors with markedly different affinities for angiotensin II and angiotensin III.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836209     DOI: 10.1016/0014-2999(88)90301-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens.

Authors:  L D Todorov; S Mihaylova-Todorova; G L Craviso; R A Bjur; D P Westfall
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

2.  Presynaptic alpha 2-autoinhibition in a vascular neuroeffector junction where ATP and noradrenaline act as co-transmitters.

Authors:  J M Bulloch; K Starke
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

3.  Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues.

Authors:  S L Cox; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Neuroeffector Ca2+ transients for the direct measurement of purine release and indirect measurement of cotransmitters in rodents.

Authors:  K L Brain
Journal:  Exp Physiol       Date:  2008-09-19       Impact factor: 2.969

5.  Modulation of neurotransmission in the guinea-pig vas deferens by capsaicin: involvement of calcitonin gene-related peptide and substance P.

Authors:  J L Ellis; G Burnstock
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

6.  Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens.

Authors:  J L Ellis; G Burnstock
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

7.  Modulation of neural noradrenaline and ATP release by angiotensin II and prostaglandin E2 in guinea-pig vas deferens.

Authors:  B Driessen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

8.  Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens.

Authors:  C S Sum; D C Wan; W T Cheung
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Effect of opioid receptor subtype-selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens.

Authors:  B Driessen; R Bültmann; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

10.  An electrophysiological study of the actions of angiotensin II at the sympathetic neuroeffector junction in the guinea-pig vas deferens.

Authors:  J Ziogas; T C Cunnane
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.